The findings from a collaboration of TSRI labs could lead to better therapies for radiation injuries and hereditary disorders such as Charcot-Marie-Tooth disease
LA JOLLA, CA—October 2, 2014—Scientists at The Scripps Research Institute (TSRI) have found that an enzyme best known for its fundamental role in building proteins has a second major function: to protect DNA during times of cellular stress.
The finding is remarkable on a basic science level but also points the way to possible therapeutic applications. Strategies that enhance the DNA-protection function of the enzyme, TyrRS, could help protect people from radiation injuries as well as from hereditary defects in DNA repair systems.
“We overexpressed TyrRS in zebrafish and found that they were totally protected from DNA damage induced by ultraviolet radiation,” said TSRI Professor Xiang-Lei Yang, who led the research.
The new finding also could lead to a better understanding of the neurodegenerative disorder known as Charcot-Marie-Tooth disease, some cases of which arise from mutations in the TyrRS gene.
The discovery, resulting from a collaboration among several TSRI laboratories, is reported online on October 2 in the journal Molecular Cell.
TyrRS (Tyrosyl tRNA synthetase) belongs to a family of evolutionarily ancient enzymes that are essential for the cellular assembly of proteins. They recognize the codes contained in gene transcripts and link them to the corresponding amino-acids—proteins’ building blocks.
TyrRS’s job is to recognize the genetic codes that specify the amino-acid tyrosine. But in recent years, TyrRS and other tRNA synthetases, which are relatively abundant in cells, have been found to have additional functions. The first of these reports came in 1999, from the laboratory of TSRI Professor Paul Schimmel, who found that TyrRS sometimes floats out of a dying cell in two pieces, each of which carries an immune-stimulating signal to other cells.
In a study reported in 2012, Yang and her colleagues found that TyrRS appears to have yet another role in the cell nucleus and may relocate there at certain times when protein-making operations slow down.
“Reduced protein synthesis is often linked to a stress response,” said Yang, “so we started looking in that direction.”
A Team Effort
For the new study, Yang worked with several collaborating laboratories at TSRI. “The breadth of expertise and the collegial environment here make that easy,” she said.
The team, including first author Research Associate Na Wei from the Yang lab, started by creating different stress conditions in several cell types. The researchers observed that only “oxidative” stress, a common stress caused by an excess of highly reactive oxygen molecules within cells, sent TyrRS into the nucleus.
What does TyrRS do in the nucleus? To learn more, the team recorded how gene expression patterns changed in cells when TyrRS flooded the nucleus. Many of these changes, they noted, were surges in activity among genes that had previously been linked to DNA protection and repair. Excluding TyrRS from the nucleus prevented those surges.
In subsequent experiments, the team was able to tease apart the molecular details of how TyrRS in the cell nucleus takes the molecular brakes off DNA damage response gene expression. They also were able to show in lab dish experiments that TyrRS’s move to the cell nucleus provides considerable protection against oxidative DNA damage—markers of such damage were much lower that way.
“We found that TyrRS promotes the most conservative and error-free homologous recombination pathway for DNA repair, which would help maintain the stability of the cell genome whenever it sustains damage,” said collaborating TSRI scientist Associate Professor Xiaohua Wu, DNA repair expert.
To confirm the physiological relevance of TyrRS’s protective role, the researchers artificially boosted TyrRS’s expression in embryonic zebrafish—effectively forcing some TyrRS into cell nuclei where it could perform its gene-activating role. The TyrRS influx turned out to provide strong protection from DNA damage caused by ultraviolet radiation. (Ionizing radiation is one of many triggers of DNA-damaging oxidative stress, although it can damage DNA directly as well.) Again, when the scientists excluded TyrRS from the zebrafish cell nuclei, the protective effect went away.
“This has been a fruitful Scripps-wide collaboration,” said TSRI Assistant Professor Shuji Kishi.” In fact, second author, Yi (‘Eric’) Shi came from the Yang lab at Scripps California, and played a key role by quickly mastering/performing all the essential skills for zebrafish in my lab at Scripps Florida. With the zebrafish model system, we were able to demonstrate TyrRS’s genome-protecting role at the level of the organism.”
“I was quite surprised to see such a clear result,” said Yang.
Potential Medical Applications
In principle, she adds, a therapy that somehow brings more TyrRS into cell nuclei, or mimics its activity there, could provide strong DNA protection for people with radiation or toxin exposure, or hereditary DNA repair defects.
Yang hopes too that TyrRS’s newly elucidated role in the nucleus will end up clarifying the mechanisms underlying Charcot-Marie-Tooth (CMT) disease, a collection of hereditary peripheral nerve degeneration syndromes that affect at least a few million people worldwide. Some cases of CMT have been linked to mutations in TyrRS’s gene, and a 2009 study found that those mutations don’t impair TyrRS’s main, enzymatic function in protein translation—which suggests TyrRS’s role in the nucleus as the next focus of investigation.
“I suspect that TyrRS’s nuclear function is relevant to CMT,” said Yang. “That hypothesis has been an important motivation for our work and it’s something we intend to pursue further.”
Other contributors to the paper, “Oxidative stress diverts tRNA synthetase to nucleus for protection against DNA damage,” included bioinformatics expert TSRI Associate Professor Andrew I. Su, whose laboratory collaborated in the study, and Yi Shi, Lan N. Truong, Kathleen M. Fisch, Tao Xu, Elisabeth Gardiner, Guangsen Fu, and Yun-Shiuan Olivia Hsu, all of TSRI.
Support for the research was provided in part by the National Institutes of Health (grants NS085092, CA102361, CA140972 and GM080677) and the National Foundation for Cancer Research.
About The Scripps Research Institute
The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs more than 2,500 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists—including two Nobel laureates and 20 members of the National Academies of Science, Engineering or Medicine—work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. In October 2016, TSRI announced a strategic affiliation with the California Institute for Biomedical Research (Calibr), representing a renewed commitment to the discovery and development of new medicines to address unmet medical needs. For more information, see www.scripps.edu.
# # #
Office of Communications